Global Hand, Foot, and Mouth Disease Treatment Market - Introduction

Hand, foot, and mouth disease (HFMD) is a contagious viral infection. It is a mild clinical syndrome, which mostly affects infants and children. It can be cured within 7 to 10 days. The most common causative agents of hand, foot, and mouth disease are coxsackievirus A16 and enterovirus A71. A supportive treatment is generally recommended for hand, foot, and mouth disease. The disease is characterized by oral enanthem, maculopapular, and macular or vesicular rashes on the hands and feet. The virus causes rashes or blisters in the mouth and on the palms of hands, soles of feet, and blisters in the mouth at the back of throat.

Global Hand, Foot, and Mouth Disease Treatment Market - Competitive Landscape

The global hand, foot, and mouth disease market is fragmented, with large number of domestic players holding majority shares in respective regions. The global market is attracting large number of domestic manufacturers. Major players operating in the global hand, foot, and mouth disease treatment market focus on business expansion, research & development, and mergers & collaborations.

Need an Overview of the Report on Hand, Foot, and Mouth Disease Treatment Market? Ask for the Brochure here

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals across the globe. The company delivers high quality and patient-centric health care solutions across the globe. It has a broad generic product portfolio, with more than 35,000 products in nearly every therapeutic area. Teva Pharmaceutical Industries operates through two business segments: generic medicines and specialty medicines.

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited is an innovation-driven global pharmaceutical company engaged in the research & development, manufacture, and marketing of novel therapeutic drugs. The company offers its products in three therapeutic areas: gastroenterology, oncology, and central nervous system. Moreover, Takeda Pharmaceutical Company develops vaccines for prevention of various infectious diseases. The company has more than 18 manufacturing sites globally and 151 subsidiary companies.

Global Hand, Foot, and Mouth Disease Treatment Market - Dynamics

Increase in Footprint of Pharmaceutical Companies in Emerging Markets

Availability of cost-effective drugs across the globe and increase in footprint of pharmaceutical manufacturers in potential markets in Asia Pacific, Latin America, and Middle East & Africa are expected to propel the global hand, foot, and mouth disease treatment market.

Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Hand, Foot, and Mouth Disease Treatment Market” here

Research & Development of Drugs and Vaccines to Drive Market

 A large number of promising novel drug candidates are in different stages of clinical trials. The anticipated approvals of novel agents such as molecular decoys, translation inhibitors, receptor antagonists, and replication inhibitors are expected to propel the global hand, foot, and mouth disease treatment market during the forecast period. Rise in health care expenditure drives demand for research & development of biologics and biosimilars for treatment of hand, foot, and mouth disease.

High Prevalence of Viral Infection Causing Hand, Foot, and Mouth Disease to Propel Market

An article published by NCBI stated that 3,605 to 9,271 cases of HFMD were reported in the Republic of Korea between 2010 and 2014, with prevalence of 1 in 3 deaths. Moreover, the socioeconomic burden ranged from US$ 80.5 Mn to US$ 164.2 Mn.

However, stringent government regulations for sale of over-the-counter hand, foot, and mouth disease drugs and lack of awareness about the disease in developing countries are likely to restrain the global hand, foot, and mouth disease treatment market.

Global Hand, Foot, and Mouth Disease Treatment Market - Segmentation

In terms of drug type, the global hand, foot, and mouth disease treatment market can be classified into:

  • Pain Relievers
  • Nucleoside Analogue Antivirals
  • Non-steroidal Anti-inflammatory Drugs
  • Others

Based on distribution channel, the global hand, foot, and mouth disease treatment market can be divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hand Foot And Mouth Disease Treatment Market

Pre Book